首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1287466篇
  免费   96104篇
  国内免费   1651篇
耳鼻咽喉   16508篇
儿科学   41558篇
妇产科学   35345篇
基础医学   192878篇
口腔科学   35051篇
临床医学   119951篇
内科学   253446篇
皮肤病学   27902篇
神经病学   103869篇
特种医学   47427篇
外国民族医学   268篇
外科学   181936篇
综合类   25984篇
现状与发展   3篇
一般理论   594篇
预防医学   106379篇
眼科学   28473篇
药学   94052篇
  7篇
中国医学   2075篇
肿瘤学   71515篇
  2018年   13900篇
  2017年   10637篇
  2016年   11642篇
  2015年   13445篇
  2014年   18548篇
  2013年   28321篇
  2012年   38838篇
  2011年   41373篇
  2010年   23909篇
  2009年   23120篇
  2008年   39095篇
  2007年   41879篇
  2006年   41463篇
  2005年   40705篇
  2004年   38965篇
  2003年   37342篇
  2002年   36223篇
  2001年   56356篇
  2000年   57317篇
  1999年   48417篇
  1998年   13743篇
  1997年   12518篇
  1996年   12900篇
  1995年   12161篇
  1994年   11338篇
  1993年   10610篇
  1992年   38450篇
  1991年   37912篇
  1990年   36665篇
  1989年   35467篇
  1988年   32885篇
  1987年   32212篇
  1986年   30723篇
  1985年   28969篇
  1984年   22124篇
  1983年   19368篇
  1982年   11559篇
  1981年   10525篇
  1979年   21069篇
  1978年   15510篇
  1977年   12916篇
  1976年   11944篇
  1975年   12910篇
  1974年   15685篇
  1973年   15447篇
  1972年   14595篇
  1971年   13634篇
  1970年   12840篇
  1969年   12113篇
  1968年   11280篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
92.
Quality of Life Research - Health-related quality of life (HRQoL) is an important indicator of population health, yet no age-specific trend analyses in HRQoL have been conducted with a nationally...  相似文献   
93.

Background

Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men diagnosed via magnetic resonance imaging (MRI)-targeted biopsies.

Objective

To assess the accuracy of available tools to predict LNI and to develop a novel model for men diagnosed via MRI-targeted biopsies.

Design, setting, and participants

A total of 497 patients diagnosed via MRI-targeted biopsies and treated with RP and extended pelvic lymph node dissection (ePLND) at five institutions were retrospectively identified.

Outcome measurements and statistical analyses

Three available models predicting LNI were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analyses. A nomogram predicting LNI was developed and internally validated.

Results and limitations

Overall, 62 patients (12.5%) had LNI. The median number of nodes removed was 15. The AUC for the Briganti 2012, Briganti 2017, and MSKCC nomograms was 82%, 82%, and 81%, respectively, and their calibration characteristics were suboptimal. A model including PSA, clinical stage and maximum diameter of the index lesion on multiparametric MRI (mpMRI), grade group on targeted biopsy, and the presence of clinically significant PCa on concomitant systematic biopsy had an AUC of 86% and represented the basis for a coefficient-based nomogram. This tool exhibited a higher AUC and higher net benefit compared to available models developed using standard biopsies. Using a cutoff of 7%, 244 ePLNDs (57%) would be spared and a lower number of LNIs would be missed compared to available nomograms (1.6% vs 4.6% vs 4.5% vs 4.2% for the new nomogram vs Briganti 2012 vs Briganti 2017 vs MSKCC).

Conclusions

Available models predicting LNI are characterized by suboptimal accuracy and clinical net benefit for patients diagnosed via MRI-targeted biopsies. A novel nomogram including mpMRI and MRI-targeted biopsy data should be used to identify candidates for ePLND in this setting.

Patient summary

We developed the first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy. Adoption of this model to identify candidates for extended pelvic lymph node dissection could avoid up to 60% of these procedures at the cost of missing only 1.6% patients with LNI.  相似文献   
94.
95.
96.
Annals of Surgical Oncology - The role of sentinel lymph node biopsy (SLNB) when ductal carcinoma in situ with microinvasion (DCISM) is identified on core biopsy is unclear. Our aim was to assess...  相似文献   
97.
98.
99.
Objective: To examine (i) the associations between physical activity dimensions, cardiorespiratory fitness and body composition and, (ii) the associations between physical activity dimensions, cardiorespiratory fitness, body composition and biomarkers of cardiometabolic health in persons with spinal cord injury (SCI).

Methods: A cross-sectional prospective cohort study with 7-day follow-up was conducted. Body composition, cardiorespiratory fitness and biomarkers of cardiometabolic health were measured in thirty-three participants with SCI (> 1 year post injury). Physical activity dimensions were objectively assessed over 7-days.

Results: Activity energy expenditure (r =.43), physical activity level (r =.39), and moderate-to-vigorous physical activity (MVPA) (r =.48) were significantly (P < 0.001) associated with absolute (L/min) peak oxygen uptake (?O2 peak). ?O2 peak was significantly higher in persons performing ≥150 MVPA minutes/week compared to <40 minutes/week (P?=?0.003). Individual physical activity dimensions were not significantly associated with biomarkers of cardiometabolic health. However, body composition characteristics (BMI, waist and hip circumference) showed significant (P < 0.04), moderate (r >.30) associations with parameters of metabolic regulation, lipid profiles and inflammatory biomarkers. Relative ?O2 peak (ml/kg/min) was moderately associated with only insulin sensitivity (r?=?0.37, P?=?0.03).

Conclusions: Physical activity dimensions are associated with cardiorespiratory fitness; however, stronger and more consistent associations suggest that poor cardiometabolic health is associated with higher body fat content. Given these findings, the regulation of energy balance should be an important consideration for researchers and clinicians looking to improve cardiometabolic health in persons with SCI.  相似文献   

100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号